BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whittaker R, Loy PA, Sisman E, Suyama E, Aza-Blanc P, Ingermanson RS, Price JH, McDonough PM. Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen. 2010;15:798-805. [PMID: 20639500 DOI: 10.1177/1087057110374991] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Singh S, Carpenter AE, Genovesio A. Increasing the Content of High-Content Screening: An Overview. J Biomol Screen 2014;19:640-50. [PMID: 24710339 DOI: 10.1177/1087057114528537] [Cited by in Crossref: 131] [Cited by in F6Publishing: 113] [Article Influence: 18.7] [Reference Citation Analysis]
2 McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G, Meng F. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med. 2014;18:197-207. [PMID: 24400890 DOI: 10.1111/jcmm.12223] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 11.0] [Reference Citation Analysis]
3 Singh AK, Aryal B, Zhang X, Fan Y, Price NL, Suárez Y, Fernández-Hernando C. Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins. Semin Cell Dev Biol 2018;81:129-40. [PMID: 29183708 DOI: 10.1016/j.semcdb.2017.11.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
4 Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res. 2011;157:241-252. [PMID: 21420035 DOI: 10.1016/j.trsl.2011.01.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 7.4] [Reference Citation Analysis]
5 Natarajan SK, Rasineni K, Ganesan M, Feng D, McVicker BL, McNiven MA, Osna NA, Mott JL, Casey CA, Kharbanda KK. Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease. Curr Mol Pharmacol 2017;10:237-48. [PMID: 26278390 DOI: 10.2174/1874467208666150817111727] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Amacher DE. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014;19:541-52. [PMID: 25189636 DOI: 10.3109/1354750X.2014.958535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes. 2011;60:1825-1831. [PMID: 21709277 DOI: 10.2337/db11-0171] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 15.4] [Reference Citation Analysis]
8 Wang XC, Zhan XR, Li XY, Yu JJ, Liu XM. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(47): 17914-17923 [PMID: 25548489 DOI: 10.3748/wjg.v20.i47.17914] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
9 Yu S, Chen E, Sherwood L, Hull M, Woods AK, Tremblay MS. Ex Vivo Cell-Based Screening Platform for Modulators of Hepatosteatosis. ACS Chem Biol 2017;12:1937-46. [DOI: 10.1021/acschembio.7b00420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Saarinen MT, Kärkkäinen O, Hanhineva K, Tiihonen K, Hibberd A, Mäkelä KA, Raza GS, Herzig KH, Anglenius H. Metabolomics analysis of plasma and adipose tissue samples from mice orally administered with polydextrose and correlations with cecal microbiota. Sci Rep 2020;10:21577. [PMID: 33299048 DOI: 10.1038/s41598-020-78484-y] [Reference Citation Analysis]
11 Huang PS, Chang CC, Wang CS, Lin KH. Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer. Biomed J 2021;44:272-84. [PMID: 33077406 DOI: 10.1016/j.bj.2020.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Rimon N, Schuldiner M. Getting the whole picture: combining throughput with content in microscopy. J Cell Sci 2011;124:3743-51. [PMID: 22124141 DOI: 10.1242/jcs.087486] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
13 叶长根, 孙水林, 白茹, 朱伟星, 陈彩萍, 谢平, 赵晖, 涂文娟, 高得勇, 刘亮明. 抗结核药物肝损伤与无肝损伤患者化疗前血循环miRNA分子的差异性表达. 世界华人消化杂志 2014; 22(3): 415-422 [DOI: 10.11569/wcjd.v22.i3.415] [Reference Citation Analysis]
14 Delik A, Dinçer S, Akkız H. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020;24:100647. [DOI: 10.1016/j.mgene.2020.100647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gerhard GS, DiStefano JK. Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 226-234 [PMID: 25729477 DOI: 10.4254/wjh.v7.i2.226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
16 McClelland AD, Kantharidis P. microRNA in the development of diabetic complications. Clin Sci (Lond). 2014;126:95-110. [PMID: 24059587 DOI: 10.1042/cs20130079] [Cited by in Crossref: 94] [Cited by in F6Publishing: 54] [Article Influence: 11.8] [Reference Citation Analysis]
17 Rodrigues Lopes I, Silva RJ, Caramelo I, Eulalio A, Mano M. Shedding light on microRNA function via microscopy-based screening. Methods 2019;152:55-64. [DOI: 10.1016/j.ymeth.2018.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Kim W, Kyung Lee E. Post-transcriptional regulation in metabolic diseases. RNA Biol 2012;9:772-80. [PMID: 22664919 DOI: 10.4161/rna.20091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
19 Mandrekar P. Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 2011; 17(20): 2456-2464 [PMID: 21633650 DOI: 10.3748/wjg.v17.i20.2456] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
20 Si Z, Guan X, Teng X, Peng X, Wan Z, Li Q, Chen G, Tan J, Li J. Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening. FASEB J 2020;34:13776-91. [PMID: 32816363 DOI: 10.1096/fj.202001067R] [Reference Citation Analysis]
21 Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 2011;15:623-36. [PMID: 21355787 DOI: 10.1517/14728222.2011.561317] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
22 Micó V, Díez-Ricote L, Daimiel L. Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health. Int J Mol Sci 2016;17:299. [PMID: 26927084 DOI: 10.3390/ijms17030299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
23 McDonough PM, Maciejewski-Lenoir D, Hartig SM, Hanna RA, Whittaker R, Heisel A, Nicoll JB, Buehrer BM, Christensen K, Mancini MG, Mancini MA, Edwards DP, Price JH. Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis. PLoS One 2013;8:e55511. [PMID: 23405163 DOI: 10.1371/journal.pone.0055511] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
24 Jia Y, Ling M, Zhang L, Jiang S, Sha Y, Zhao R. Downregulation of miR-150 Expression by DNA Hypermethylation Is Associated with High 2-Hydroxy-(4-methylthio)butanoic Acid-Induced Hepatic Cholesterol Accumulation in Nursery Piglets. J Agric Food Chem 2016;64:7530-9. [DOI: 10.1021/acs.jafc.6b03615] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
26 Walther TC, Chung J, Farese RV Jr. Lipid Droplet Biogenesis. Annu Rev Cell Dev Biol 2017;33:491-510. [PMID: 28793795 DOI: 10.1146/annurev-cellbio-100616-060608] [Cited by in Crossref: 232] [Cited by in F6Publishing: 221] [Article Influence: 58.0] [Reference Citation Analysis]
27 Mahdy MM, El-Ekiaby NM, Hashish RM, Salah RA, Hanafi RS, Azzazy HM, Abdelaziz AI. miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1. J Clin Transl Hepatol 2016;4:293-9. [PMID: 28097097 DOI: 10.14218/JCTH.2016.00046] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Lou-Bonafonte JM, Arnal C, Osada J. New genes involved in hepatic steatosis. Curr Opin Lipidol. 2011;22:159-164. [PMID: 21494144 DOI: 10.1097/mol.0b013e3283462288] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Nie YQ, Cao J, Zhou YJ, Liang X, Du YL, Wan YJ, Li YY. The effect of miRNA-122 in regulating fat deposition in a cell line model. J Cell Biochem. 2014;115:839-846. [PMID: 24288170 DOI: 10.1002/jcb.24725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 McDonough PM, Ingermanson RS, Loy PA, Koon ED, Whittaker R, Laris CA, Hilton JM, Nicoll JB, Buehrer BM, Price JH. Quantification of hormone sensitive lipase phosphorylation and colocalization with lipid droplets in murine 3T3L1 and human subcutaneous adipocytes via automated digital microscopy and high-content analysis. Assay Drug Dev Technol 2011;9:262-80. [PMID: 21186937 DOI: 10.1089/adt.2010.0302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
31 Benatti RO, Melo AM, Borges FO, Ignacio-souza LM, Simino LAP, Milanski M, Velloso LA, Torsoni MA, Torsoni AS. Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 ( miR-122 ) and microRNA-370 ( miR-370 ) expression in offspring. Br J Nutr 2014;111:2112-22. [DOI: 10.1017/s0007114514000579] [Cited by in Crossref: 89] [Cited by in F6Publishing: 43] [Article Influence: 12.7] [Reference Citation Analysis]
32 Targett-Adams P, Graham EJ, Middleton J, Palmer A, Shaw SM, Lavender H, Brain P, Tran TD, Jones LH, Wakenhut F. Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action. J Virol. 2011;85:6353-6368. [PMID: 21507963 DOI: 10.1128/jvi.00215-11] [Cited by in Crossref: 90] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
33 Tao J, Jiang L, Chen X. Roles of microRNA in liver cancer. Liver Research 2018;2:61-72. [DOI: 10.1016/j.livres.2018.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
34 Yap CS, Sinha RA, Ota S, Katsuki M, Yen PM. Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells. Biochem Biophys Res Commun 2013;440:635-9. [PMID: 24103759 DOI: 10.1016/j.bbrc.2013.09.116] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
35 El-Ekiaby NM, Mekky RY, El Sobky SA, Elemam NM, El-Sayed M, Esmat G, Abdelaziz AI. Epigenetic harnessing of HCV via modulating the lipid droplet-protein, TIP47, in HCV cell models. FEBS Lett 2015;589:2266-73. [PMID: 26170028 DOI: 10.1016/j.febslet.2015.06.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
37 Vickers KC, Sethupathy P, Baran-Gale J, Remaley AT. Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J Lipid Res 2013;54:1182-91. [PMID: 23505317 DOI: 10.1194/jlr.R034801] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
38 Chen SZ, Ning LF, Xu X, Jiang WY, Xing C, Jia WP, Chen XL, Tang QQ, Huang HY. The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling. Cell Death Differ 2016;23:1778-91. [PMID: 27447109 DOI: 10.1038/cdd.2016.66] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
39 Soronen J, Yki-Järvinen H, Zhou Y, Sädevirta S, Sarin AP, Leivonen M, Sevastianova K, Perttilä J, Laurila PP, Sigruener A, Schmitz G, Olkkonen VM. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease. Physiol Rep 2016;4:e12661. [PMID: 26733244 DOI: 10.14814/phy2.12661] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
40 Sun B, Karin M. Inflammation and liver tumorigenesis. Front Med. 2013;7:242-254. [PMID: 23681888 DOI: 10.1007/s11684-013-0256-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
41 Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(45): 6546-6551 [PMID: 23236228 DOI: 10.3748/wjg.v18.i45.6546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
42 Engin AB. MicroRNA and Adipogenesis. In: Engin AB, Engin A, editors. Obesity and Lipotoxicity. Cham: Springer International Publishing; 2017. pp. 489-509. [DOI: 10.1007/978-3-319-48382-5_21] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
43 Eulalio A, Mano M. MicroRNA Screening and the Quest for Biologically Relevant Targets. J Biomol Screen 2015;20:1003-17. [DOI: 10.1177/1087057115578837] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
44 Bladé C, Baselga-Escudero L, Salvadó MJ, Arola-Arnal A. miRNAs, polyphenols, and chronic disease. Mol Nutr Food Res 2013;57:58-70. [PMID: 23165995 DOI: 10.1002/mnfr.201200454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
45 El-Ekiaby NM, Mekky RY, Riad SE, Elhelw DS, El-Sayed M, Esmat G, Abdelaziz AI. miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models. J Med Virol 2017;89:653-9. [PMID: 27591428 DOI: 10.1002/jmv.24677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Abu-Farha M, Cherian P, Al-Khairi I, Nizam R, Alkandari A, Arefanian H, Tuomilehto J, Al-Mulla F, Abubaker J. Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3. Sci Rep 2019;9:11866. [PMID: 31413305 DOI: 10.1038/s41598-019-48371-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
47 Ali AS, Ali S, Ahmad A, Bao B, Philip PA, Sarkar FH. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2011;12:1050-1062. [PMID: 21767342 DOI: 10.1111/j.1467-789x.2011.00906.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
48 Peixoto TC, Gaspar de Moura E, Quitete FT, Simino LA, Torsoni AS, Torsoni MA, Manhaes AC, Lisboa PC. Early life nicotine exposure alters mRNA and microRNA expressions related to thyroid function and lipid metabolism in liver and BAT of adult wistar rats. Mol Cell Endocrinol 2021;523:111141. [PMID: 33359828 DOI: 10.1016/j.mce.2020.111141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Abbey D, Conlon D, Rainville C, Elwyn S, Quiroz-Figueroa K, Billheimer J, Schultz DC, Hand NJ, Cherry S, Rader DJ. Lipid droplet screen in human hepatocytes identifies TRRAP as a regulator of cellular triglyceride metabolism. Clin Transl Sci 2021;14:1369-79. [PMID: 34156146 DOI: 10.1111/cts.12988] [Reference Citation Analysis]
50 Serva A, Claas C, Starkuviene V. A Potential of microRNAs for High-Content Screening. J Nucleic Acids 2011;2011:870903. [PMID: 21922044 DOI: 10.4061/2011/870903] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]